Furthermore, the overexpression of SOX9 significantly alleviated the effects of LDHA silencing on activated HSCs, suggesting that SOX9 operates downstream of H3K18 lactylation in the promotion of liver fibrosis (Wu S. et al., 2024). The gene discussed is SOX9; the disease is Hepatic fibrosis.